Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
Yahoo Finance
Thu, 04/17/25 - 11:28 am
BigHat Biosciences
Eli Lilly
drug discovery
artificial intelligence
machine learning
Verve’s shares jump by more than 26% on Lilly-partnered gene therapy data
Clinical Trials Arena
Tue, 04/15/25 - 11:11 am
Verve Therapeutics
VERVE-102
gene editing
Eli Lilly
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
HHS leaves door open to future Medicare coverage of obesity drugs
BioSpace
Tue, 04/8/25 - 11:54 am
HHS
Medicare
obesity
Eli Lilly
Novo Nordisk
Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
CNBC
Sun, 04/6/25 - 11:40 pm
Donald Trump
Medicare
obesity
GLP-1 agonist
Eli Lilly
Novo Nordisk
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal
Fierce Biotech
Thu, 04/3/25 - 10:14 pm
Sangamo Therapeutics
Eli Lilly
neurotropics
gene therapy
5 Big Pharmas Push Boundaries in Radiopharmaceuticals
BioSpace
Wed, 04/2/25 - 11:38 am
radiopharmaceuticals
Novartis
Bayer
AstraZeneca
Bristol Myers Squibb
Eli Lilly
Hims & Hers to sell Lilly’s weight-loss drug on its telehealth platform
Investing.com
Tue, 04/1/25 - 11:28 pm
Hims & Hers Health
Eli Lilly
telehealth
Eli Lilly Sues Pharmacies Over Unauthorized Tirzepatide Compounding
NASDAQ
Tue, 04/1/25 - 11:23 pm
Eli Lilly
compounding
tirzepatide
Eli Lilly’s lepodisiran cuts lipoprotein(a) by 93.9% in Phase II trial
Clinical Trials Arena
Mon, 03/31/25 - 10:55 am
Eli Lilly
lepodisiran
clinical trials
heart disease
European committee says Lilly Alzheimer's drug shouldn't get marketing approval
Yahoo/AP
Fri, 03/28/25 - 11:13 am
Eli Lilly
Kisunla
Europe
Alzheimer's disease
EMA
Lilly adds Alzheimer’s disease care to DTC telehealth platform
Fierce Pharma
Thu, 03/27/25 - 10:40 pm
Eli Lilly
LillyDirect
DTC
Alzheimer's disease
Lilly, Novo expand DTC reach of obesity meds after compound win
Pharma Voice
Mon, 03/24/25 - 10:58 am
Eli Lilly
Novo Nordisk
obesity
DTC
Mounjaro
Wegovy
Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial
MSN/Reuters
Thu, 03/20/25 - 10:18 am
Eli Lilly
Mounjaro
India
weight loss
Novo Nordisk
Lilly backs precision medicine start-up’s $65 million raise
Chemical and Engineering News
Wed, 03/19/25 - 11:16 am
Ampersand Biosciences
Eli Lilly
funding
cancer
Flagship Pioneering
Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program
Fierce Pharma
Tue, 03/18/25 - 11:00 pm
Teva Pharmaceutical
JNJ
Eli Lilly
Pfizer
Sanofi
legal
Inflation Reduction Act
Lilly, J&J boosted spending on executive security after UnitedHealth shooting
MSN/Reuters
Thu, 03/13/25 - 11:46 am
JNJ
Eli Lilly
executives
UnitedHealth
security
Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024
Yahoo Finance
Wed, 03/12/25 - 11:27 am
Eli Lilly
Pharma CEOs
David Ricks
executive compensation
Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says
MSN/Reuters
Mon, 03/10/25 - 11:09 pm
Eli Lilly
Mounjaro
China
India
Mexico
Brazil
emerging markets
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »